Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 7, 2008; 14(1): 58-63
Published online Jan 7, 2008. doi: 10.3748/wjg.14.58
Published online Jan 7, 2008. doi: 10.3748/wjg.14.58
Child-Pugh classification[24] | A | B | C | |
Encephalopathy | none | mild | coma | |
Ascites | none | responsive | unresponsive | |
Serum bilirubin (mg/dL) | < 2.0 | 2.0-3.0 | > 3.0 | |
Serum albumin (g/dL) | > 3.5 | 2.8-3.5 | < 2.8 | |
Prothrombin activity (%) | > 70 | 40-70 | < 40 | |
Liver damage grade[17] | A | B | C | |
Ascites | none | responsive | unresponsive | |
Serum bilirubin (mg/dL) | < 2.0 | 2.0-3.0 | > 3.0 | |
Serum albumin (g/dL) | > 3.5 | 3.0-3.5 | < 3.0 | |
ICG R15 (%) | < 15 | 15-40 | > 40 | |
Prothrombin activity (%) | > 80 | 50-80 | < 50 |
- Citation: Nanashima A, Masuda J, Miuma S, Sumida Y, Nonaka T, Tanaka K, Hidaka S, Sawai T, Nagayasu T. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol 2008; 14(1): 58-63
- URL: https://www.wjgnet.com/1007-9327/full/v14/i1/58.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.58